Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries

BACKGROUND: A novel meningococcal multicomponent vaccine, 4CMenB (Bexsero(®)), has been approved in Europe, Canada, Australia and US. The potential impact of 4CMenB on strain coverage is being estimated by using Meningococcal Antigen Typing System (MATS), an ELISA assay which measures vaccine antige...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Abad, Raquel, Medina, Verónica, Stella, Maria, Boccadifuoco, Giuseppe, Comanducci, Maurizio, Bambini, Stefania, Muzzi, Alessandro, Vázquez, Julio A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780694/
https://ncbi.nlm.nih.gov/pubmed/26950303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0150721
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi